Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study.

[1]  David Bruce Lewis,et al.  High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data From the EPIC-NSW Trial , 2021, Journal of acquired immune deficiency syndromes.

[2]  G. Prestage,et al.  Australian Gay and Bisexual Men Who Use Condoms, PrEP or Rarely Practise HIV Risk Reduction with Casual Sex Partners: An Analysis of National, Behavioural Surveillance Data, 2017–2018 , 2020, AIDS and Behavior.

[3]  Denton Callander,et al.  Australian ‘gayborhoods’ and ‘lesborhoods’: a new method for estimating the number and prevalence of adult gay men and lesbian women living in each Australian postcode , 2020, Int. J. Geogr. Inf. Sci..

[4]  S. Buchbinder,et al.  PrEP Persistence is a Critical Issue in PrEP Implementation. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  V. Veloso,et al.  Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline. , 2019, The lancet. HIV.

[6]  E. Vittinghoff,et al.  Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics. , 2019, AIDS.

[7]  J. Baeten,et al.  Global implementation of PrEP for HIV prevention: setting expectations for impact , 2019, Journal of the International AIDS Society.

[8]  Z. R. Greenwald,et al.  Cohort profile: l’Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada , 2019, BMJ Open.

[9]  A. Siegler,et al.  Persistence on HIV preexposure prophylaxis medication over a 2‐year period among a national sample of 7148 PrEP users, United States, 2015 to 2017 , 2019, Journal of the International AIDS Society.

[10]  K. Mayer,et al.  Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care , 2019, Journal of the International AIDS Society.

[11]  D. Cooper,et al.  Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. , 2018, The lancet. HIV.

[12]  M. Golden,et al.  Patient Disengagement From an HIV Preexposure Prophylaxis Program in a Sexually Transmitted Disease Clinic , 2018, Sexually transmitted diseases.

[13]  D. Cooper,et al.  The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90‐90‐90 targets , 2018, Journal of the International AIDS Society.

[14]  D. Cooper,et al.  Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial , 2018, BMC Public Health.

[15]  D. Havlir,et al.  Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. , 2018, The lancet. HIV.

[16]  A. McNulty,et al.  Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE , 2016, BMJ Open.

[17]  Sheena McCormack,et al.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial , 2016, The Lancet.

[18]  M. Mimiaga,et al.  Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities , 2016, Journal of the International AIDS Society.

[19]  M. Mimiaga,et al.  Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM) , 2016, AIDS and Behavior.

[20]  David Thompson,et al.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. , 2015, The New England journal of medicine.

[21]  J. Baeten,et al.  Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. , 2015, AIDS.

[22]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.